Minimal residual disease program for acute lymphoblastic leukemia at Dhahran Health Center

Minimal residual disease program for acute lymphoblastic leukemia at Dhahran Health Center

Background and Objectives: Minimal residual disease (MRD) assays for monitoring acute lymphoblastic leukemia (ALL) during treatment are defined as assays with a limit of detection of at least 0.01% leukemic blasts per mononuclear cells or total nucleated cells. Settings and Design: We retrospectivel...

Full description

Bibliographic Details
Main Authors: Nasir Khalid Amra, Salwa Shaberdeen Sheikh, Basel A Abushullaih, Nafeesa A Al-Faris, Adil A Al-Khatti, Huda H Al-Sayed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Applied Hematology
Subjects:
Acute lymphoblastic disease
flow cytometry
minimal residual disease
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2016;volume=7;issue=1;spage=17;epage=23;aulast=Amra

Internet

http://www.jahjournal.org/article.asp?issn=1658-5127;year=2016;volume=7;issue=1;spage=17;epage=23;aulast=Amra

Similar Items